The Development, Safety, and Feasibility of an Artificial Intelligence-Powered Platform (NodeAI) for Real-Time Prediction of Mediastinal Lymph Node Malignancy During Endobronchial Ultrasound Staging for Lung Cancer

NCT06540196 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

600

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer
Non Small Cell Lung Cancer

Interventions

DIAGNOSTIC_TEST: NodeAI
DIAGNOSTIC_TEST: Surgeon

Sponsor

St. Joseph's Healthcare Hamilton